Additional file 2 of Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
Additional file 2: Fig. S1 High-affinity binding of the TfRMAb-TNFR to the TfR (A) and TNF-α (B). iPSC-derived brain endothelial cells (ihBMECs) cultured in Transwell inserts were treated with 1 µg/mL TNF-α and 7 µg/mL TfRMAb-TNFR for up to 3 days. TNF-α reduced TEER (C) and increased sodium fluores...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Bild |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Ou, Weijun Yang, Joshua Simanauskaite, Juste Choi, Matthew Castellanos, Demi M. Chang, Rudy Sun, Jiahong Jagadeesan, Nataraj Parfitt, Karen D. Cribbs, David H. Sumbria, Rachita K. |
description | Additional file 2: Fig. S1 High-affinity binding of the TfRMAb-TNFR to the TfR (A) and TNF-α (B). iPSC-derived brain endothelial cells (ihBMECs) cultured in Transwell inserts were treated with 1 µg/mL TNF-α and 7 µg/mL TfRMAb-TNFR for up to 3 days. TNF-α reduced TEER (C) and increased sodium fluorescein passage across the brain endothelial monolayer (D). These effects were normalized by TfRMAb-TNFR treatment. All the experiments were repeated three times independently and data were expressed as mean ± SEM. Two-way repeated-measures ANOVA or one-way ANOVA with Holm Sidak’s post hoc test was used in C and D, respectively. *p |
doi_str_mv | 10.6084/m9.figshare.17711039 |
format | Image |
fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_17711039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_17711039</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_177110393</originalsourceid><addsrcrecordid>eNqdj0FOwzAQRb1hgYAbsJgDtGlMq5YsAVGxYtW9NY2dZCTbE42dRe7BRbhIz4SD6AVYjL5m8d_XU-pR19W-ft5tQlN11KcBxVX6cNC63ja36uvFWsrEET105B08AXfwSuy5pxZOn8f15RsoDnSmzJJAnJ1aB4Fa4d4TJ0oriG6SX4TnVF6MFjJOMA6cysnscZkoGEDIgjH1LhZ64CkVFFvnl9VS4RHzMN-rmw59cg9_ead2x_fT28faYsaWsjOjUECZja7NImdCY65y5iq3_WftB_cEZlk</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Additional file 2 of Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy</title><source>DataCite</source><creator>Ou, Weijun ; Yang, Joshua ; Simanauskaite, Juste ; Choi, Matthew ; Castellanos, Demi M. ; Chang, Rudy ; Sun, Jiahong ; Jagadeesan, Nataraj ; Parfitt, Karen D. ; Cribbs, David H. ; Sumbria, Rachita K.</creator><creatorcontrib>Ou, Weijun ; Yang, Joshua ; Simanauskaite, Juste ; Choi, Matthew ; Castellanos, Demi M. ; Chang, Rudy ; Sun, Jiahong ; Jagadeesan, Nataraj ; Parfitt, Karen D. ; Cribbs, David H. ; Sumbria, Rachita K.</creatorcontrib><description>Additional file 2: Fig. S1 High-affinity binding of the TfRMAb-TNFR to the TfR (A) and TNF-α (B). iPSC-derived brain endothelial cells (ihBMECs) cultured in Transwell inserts were treated with 1 µg/mL TNF-α and 7 µg/mL TfRMAb-TNFR for up to 3 days. TNF-α reduced TEER (C) and increased sodium fluorescein passage across the brain endothelial monolayer (D). These effects were normalized by TfRMAb-TNFR treatment. All the experiments were repeated three times independently and data were expressed as mean ± SEM. Two-way repeated-measures ANOVA or one-way ANOVA with Holm Sidak’s post hoc test was used in C and D, respectively. *p<0.05, ***p<0.001, ***p<0.0001. OD: optical density.</description><identifier>DOI: 10.6084/m9.figshare.17711039</identifier><language>eng</language><publisher>figshare</publisher><subject>Biochemistry ; Biotechnology ; Cell Biology ; FOS: Biological sciences ; FOS: Clinical medicine ; FOS: Health sciences ; Immunology ; Medicine ; Mental Health ; Molecular Biology ; Neuroscience ; Pharmacology ; Physiology</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-7459-0723</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>777,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.17711039$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ou, Weijun</creatorcontrib><creatorcontrib>Yang, Joshua</creatorcontrib><creatorcontrib>Simanauskaite, Juste</creatorcontrib><creatorcontrib>Choi, Matthew</creatorcontrib><creatorcontrib>Castellanos, Demi M.</creatorcontrib><creatorcontrib>Chang, Rudy</creatorcontrib><creatorcontrib>Sun, Jiahong</creatorcontrib><creatorcontrib>Jagadeesan, Nataraj</creatorcontrib><creatorcontrib>Parfitt, Karen D.</creatorcontrib><creatorcontrib>Cribbs, David H.</creatorcontrib><creatorcontrib>Sumbria, Rachita K.</creatorcontrib><title>Additional file 2 of Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy</title><description>Additional file 2: Fig. S1 High-affinity binding of the TfRMAb-TNFR to the TfR (A) and TNF-α (B). iPSC-derived brain endothelial cells (ihBMECs) cultured in Transwell inserts were treated with 1 µg/mL TNF-α and 7 µg/mL TfRMAb-TNFR for up to 3 days. TNF-α reduced TEER (C) and increased sodium fluorescein passage across the brain endothelial monolayer (D). These effects were normalized by TfRMAb-TNFR treatment. All the experiments were repeated three times independently and data were expressed as mean ± SEM. Two-way repeated-measures ANOVA or one-way ANOVA with Holm Sidak’s post hoc test was used in C and D, respectively. *p<0.05, ***p<0.001, ***p<0.0001. OD: optical density.</description><subject>Biochemistry</subject><subject>Biotechnology</subject><subject>Cell Biology</subject><subject>FOS: Biological sciences</subject><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>Immunology</subject><subject>Medicine</subject><subject>Mental Health</subject><subject>Molecular Biology</subject><subject>Neuroscience</subject><subject>Pharmacology</subject><subject>Physiology</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2022</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqdj0FOwzAQRb1hgYAbsJgDtGlMq5YsAVGxYtW9NY2dZCTbE42dRe7BRbhIz4SD6AVYjL5m8d_XU-pR19W-ft5tQlN11KcBxVX6cNC63ja36uvFWsrEET105B08AXfwSuy5pxZOn8f15RsoDnSmzJJAnJ1aB4Fa4d4TJ0oriG6SX4TnVF6MFjJOMA6cysnscZkoGEDIgjH1LhZ64CkVFFvnl9VS4RHzMN-rmw59cg9_ead2x_fT28faYsaWsjOjUECZja7NImdCY65y5iq3_WftB_cEZlk</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Ou, Weijun</creator><creator>Yang, Joshua</creator><creator>Simanauskaite, Juste</creator><creator>Choi, Matthew</creator><creator>Castellanos, Demi M.</creator><creator>Chang, Rudy</creator><creator>Sun, Jiahong</creator><creator>Jagadeesan, Nataraj</creator><creator>Parfitt, Karen D.</creator><creator>Cribbs, David H.</creator><creator>Sumbria, Rachita K.</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope><orcidid>https://orcid.org/0000-0002-7459-0723</orcidid></search><sort><creationdate>20220101</creationdate><title>Additional file 2 of Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy</title><author>Ou, Weijun ; Yang, Joshua ; Simanauskaite, Juste ; Choi, Matthew ; Castellanos, Demi M. ; Chang, Rudy ; Sun, Jiahong ; Jagadeesan, Nataraj ; Parfitt, Karen D. ; Cribbs, David H. ; Sumbria, Rachita K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_177110393</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biochemistry</topic><topic>Biotechnology</topic><topic>Cell Biology</topic><topic>FOS: Biological sciences</topic><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>Immunology</topic><topic>Medicine</topic><topic>Mental Health</topic><topic>Molecular Biology</topic><topic>Neuroscience</topic><topic>Pharmacology</topic><topic>Physiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Ou, Weijun</creatorcontrib><creatorcontrib>Yang, Joshua</creatorcontrib><creatorcontrib>Simanauskaite, Juste</creatorcontrib><creatorcontrib>Choi, Matthew</creatorcontrib><creatorcontrib>Castellanos, Demi M.</creatorcontrib><creatorcontrib>Chang, Rudy</creatorcontrib><creatorcontrib>Sun, Jiahong</creatorcontrib><creatorcontrib>Jagadeesan, Nataraj</creatorcontrib><creatorcontrib>Parfitt, Karen D.</creatorcontrib><creatorcontrib>Cribbs, David H.</creatorcontrib><creatorcontrib>Sumbria, Rachita K.</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ou, Weijun</au><au>Yang, Joshua</au><au>Simanauskaite, Juste</au><au>Choi, Matthew</au><au>Castellanos, Demi M.</au><au>Chang, Rudy</au><au>Sun, Jiahong</au><au>Jagadeesan, Nataraj</au><au>Parfitt, Karen D.</au><au>Cribbs, David H.</au><au>Sumbria, Rachita K.</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Additional file 2 of Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy</title><date>2022-01-01</date><risdate>2022</risdate><abstract>Additional file 2: Fig. S1 High-affinity binding of the TfRMAb-TNFR to the TfR (A) and TNF-α (B). iPSC-derived brain endothelial cells (ihBMECs) cultured in Transwell inserts were treated with 1 µg/mL TNF-α and 7 µg/mL TfRMAb-TNFR for up to 3 days. TNF-α reduced TEER (C) and increased sodium fluorescein passage across the brain endothelial monolayer (D). These effects were normalized by TfRMAb-TNFR treatment. All the experiments were repeated three times independently and data were expressed as mean ± SEM. Two-way repeated-measures ANOVA or one-way ANOVA with Holm Sidak’s post hoc test was used in C and D, respectively. *p<0.05, ***p<0.001, ***p<0.0001. OD: optical density.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.17711039</doi><orcidid>https://orcid.org/0000-0002-7459-0723</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.6084/m9.figshare.17711039 |
ispartof | |
issn | |
language | eng |
recordid | cdi_datacite_primary_10_6084_m9_figshare_17711039 |
source | DataCite |
subjects | Biochemistry Biotechnology Cell Biology FOS: Biological sciences FOS: Clinical medicine FOS: Health sciences Immunology Medicine Mental Health Molecular Biology Neuroscience Pharmacology Physiology |
title | Additional file 2 of Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T22%3A01%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Ou,%20Weijun&rft.date=2022-01-01&rft_id=info:doi/10.6084/m9.figshare.17711039&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_17711039%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |